188 related articles for article (PubMed ID: 15985047)
1. Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors.
Behan K; Cutts C; Tett SE
J Clin Pharm Ther; 2005 Aug; 30(4):337-43. PubMed ID: 15985047
[TBL] [Abstract][Full Text] [Related]
2. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Joshua FF; Oakley SP; Major GA
Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
[TBL] [Abstract][Full Text] [Related]
3. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
Schneeweiss S; Glynn RJ; Avorn J; Solomon DH
J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677
[TBL] [Abstract][Full Text] [Related]
4. Emergency contraception. General practitioner knowledge, attitudes and practices in New South Wales.
Weisberg E; Fraser IS; Carrick SE; Wilde FM
Med J Aust; 1995 Feb; 162(3):136-8. PubMed ID: 7854225
[TBL] [Abstract][Full Text] [Related]
5. Treating osteoarthritis in practice--the TOP Study.
Knott L
Curr Med Res Opin; 2000; 16(2):147-52. PubMed ID: 10893659
[TBL] [Abstract][Full Text] [Related]
6. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
7. Influences on doctors' prescribing: is geographical remoteness a factor?
Cutts C; Tett SE
Aust J Rural Health; 2003 Jun; 11(3):124-30. PubMed ID: 12950395
[TBL] [Abstract][Full Text] [Related]
8. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
Dai C; Stafford RS; Alexander GC
Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France.
Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C
Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and potential risks in a convenience sample of general practitioners.
Cutts C; LaCaze A
Aust Fam Physician; 2002 Jun; 31(6):590-2. PubMed ID: 12154611
[TBL] [Abstract][Full Text] [Related]
11. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD
Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848
[TBL] [Abstract][Full Text] [Related]
12. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
Barozzi N; Tett SE
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
[TBL] [Abstract][Full Text] [Related]
13. Do rural consumers expect a prescription from their GP visit? Investigation of patients' expectations for a prescription and doctors' prescribing decisions in rural Australia.
Cutts C; Tett SE
Aust J Rural Health; 2005 Feb; 13(1):43-50. PubMed ID: 15720314
[TBL] [Abstract][Full Text] [Related]
14. A rural/urban comparison of the roles of the general practitioner in colorectal cancer management.
Hanks H; Veitch PC; Harris MF
Aust J Rural Health; 2008 Dec; 16(6):376-82. PubMed ID: 19032211
[TBL] [Abstract][Full Text] [Related]
15. Identification of barriers to the implementation of evidence-based practice for pre-hospital thrombolysis.
Bloe C; Mair C; Call A; Fuller A; Menzies S; Leslie SJ
Rural Remote Health; 2009; 9(1):1100. PubMed ID: 19278299
[TBL] [Abstract][Full Text] [Related]
16. Prescriber adoption of newly approved selective COX-2 inhibitors.
Layton D; Souverein PC; Heerdink ER; Shakir SA; Egberts AG
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1168-74. PubMed ID: 18821717
[TBL] [Abstract][Full Text] [Related]
17. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Depont F; Fourrier A; Merlière Y; Droz C; Amouretti M; Bégaud B; Bénichou J; Moride Y; Velo GP; Sturkenboom M; Blin P; Moore N;
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):891-900. PubMed ID: 17351983
[TBL] [Abstract][Full Text] [Related]
18. How do rural GPs manage their inactive and overweight patients?--A pilot study of rural GPs in Queensland.
Eley DS; Eley RM
Aust Fam Physician; 2009 Sep; 38(9):747-8. PubMed ID: 19893808
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors: perspectives of patients and their GPs.
Grime J; Pollock K; Blenkinsopp A
Br J Gen Pract; 2001 Sep; 51(470):703-11. PubMed ID: 11593830
[TBL] [Abstract][Full Text] [Related]
20. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
